Valuation Allowances and Deferred Tax Assets for Insurance Companies

Valuation Allowances, Admissibility, and Deferred Tax Assets: Navigating a Challenging Environment for Insurance Companies

May 26, 2026

Article Summary

• Deferred tax assets are evaluated differently under GAAP and statutory accounting, making it critical for insurance companies to understand how valuation allowances and admissibility rules interact in practice.

• Under GAAP, companies must determine whether deferred tax assets are more likely than not to be realized, while statutory accounting applies additional admissibility limitations only after valuation allowances are considered.

• Auditors and regulators continue to place greater emphasis on objective, well documented evidence supporting deferred tax asset realization, especially when companies have cumulative losses or significant net operating losses.

• Insurance companies should look beyond net operating losses and evaluate other book-to-tax differences, including loss reserves, deferred acquisition costs, depreciation, and investment accounting, when assessing deferred tax assets and liabilities.

• Successful deferred tax asset analysis requires ongoing coordination across tax, finance, actuarial, and operational teams to ensure assumptions, forecasts, and supporting documentation remain aligned and sustainable over time.

While the underlying accounting standards related to deferred tax assets (DTAs) are well established, applying them in practice often requires significant judgment, particularly when net operating losses (NOLs) are the largest contributing factor.

There are differences in DTA treatments between GAAP financial reporting, statutory accounting requirements, and management expectations, especially in an environment where regulators and auditors emphasize supportability and consistency.

At the center of these discussions are two related but distinct concepts: valuation allowances under GAAP and admissibility under statutory accounting.

Two Frameworks, Two Outcomes

Under GAAP, the realization of deferred tax assets is evaluated using the familiar “more likely than not” standard. Companies must determine whether it is more than 50 percent likely that DTAs will be realized through future taxable income, reversal of existing temporary differences, or tax planning strategies. When that standard cannot be met, a valuation allowance is required.

Importantly, this evaluation occurs before any consideration of statutory accounting. In other words, the valuation allowance establishes the net deferred tax asset that remains after reducing DTAs for any amounts not expected to be realized.

Statutory accounting then applies a more conservative framework—but only to that net amount. Admissibility testing does not apply to gross DTAs. If a deferred tax asset is fully offset by a valuation allowance, there is no remaining asset to evaluate for admissibility.

Where DTAs remain after the valuation allowance analysis, statutory accounting determines whether, and to what extent, those net assets are admitted for purposes of statutory surplus. This involves additional limitations related to reversal timing and surplus thresholds, and it often results in partial or full non-admissibility—even when no valuation allowance is required.

The Role of Evidence in a Valuation Allowance Analysis

One of the most challenging aspects of evaluating deferred tax assets is the weighting of positive and negative evidence.

Negative evidence is typically straightforward. Cumulative losses, recent operating results, and adverse industry trends are all highly visible indicators. Because they are grounded in historical performance, they tend to carry significant weight and are difficult to overcome.

Positive evidence, by contrast, is more difficult to establish. It must be based on objectively verifiable information and cannot rely solely on projections or optimistic forecasts. While future taxable income is inherently forward-looking, the support behind those projections must be tied to real, observable factors—such as existing business already in force, contractual arrangements, or established trends that are already underway.

This distinction becomes particularly important when significant negative evidence exists. In those situations, the threshold for sufficient positive evidence increases. Auditors and regulators placing great emphasis on whether the evidence supporting realization is not only reasonable, but also well documented and consistent with broader financial assumptions.

In practice, this means that supporting a deferred tax asset is not simply a matter of demonstrating a path to profitability. It requires evidence that can withstand scrutiny today—not just expectations about tomorrow.

Looking Beyond Net Operating Losses

Although NOLs often drive the conversation, a comprehensive valuation allowance analysis must consider all underlying book-to-tax differences that contribute to DTAs and deferred tax liabilities (DTLs).

In the insurance industry, certain differences are particularly significant. Loss reserves, for example, are often discounted for tax purposes, which delays deductions relative to financial reporting and creates deferred tax liabilities. These DTLs can serve as a reliable source of future taxable income, especially because their reversal patterns are generally prescribed and predictable.

Other differences—including those related to deferred acquisition costs (DAC), depreciation, and investment accounting—also create DTLs that reverse over time. When those reversals occur within the applicable carryforward period, they may provide meaningful support for the realization of NOLs or other DTAs.

At the same time, not all sources of potential taxable income carry equal weight. DTLs tied to structural differences with predictable reversal patterns tend to be viewed as stronger positive evidence than items dependent on discretionary actions or uncertain future events.

A thorough analysis requires not only identifying these differences, but also evaluating their timing, reliability, and interaction.

Managing Management Expectations

Another dynamic that consistently arises in these discussions is the natural pressure on management to avoid valuation allowances or non-admitted assets.

From a financial reporting perspective, these adjustments can reduce earnings under GAAP and decrease statutory surplus--lowering the company's risk based capital (RBC). They may also raise concerns with boards, regulators, or rating agencies. As a result, there is often a strong preference to support full realization wherever possible.

However, a balanced and realistic approach is required. In that context, managing expectations early is critical. Helping stakeholders understand that valuation allowances and non-admitted DTAs are not necessarily signs of underperformance—but rather outcomes of conservative accounting frameworks—can lead to more effective and less contentious discussions.

It is also important to recognize that the valuation allowance analysis is not static. Deferred tax assets are evaluated each reporting period, and the conclusion may change over time as facts and circumstances evolve. So, a company that records a valuation allowance in one year is not locked into that position indefinitely. Improvements in operating results, changes in forecasts, or the emergence of stronger positive evidence may support the reduction—or even elimination—of a valuation allowance in future periods.

Conversely, deterioration in performance or the emergence of additional negative evidence may require an increase in an existing allowance.

This dynamic aspect of the analysis reinforces the need for ongoing monitoring, documentation, and alignment across functions.

Conclusion

Ultimately, the successful evaluation of deferred tax assets requires more than technical compliance. It depends on coordination across tax, finance, actuarial, and operational teams—and on a consistent, well-supported narrative around future performance.

Organizations that approach this proactively tend to be better positioned. They align forecasts across departments, clearly document assumptions, and evaluate not only whether a position can be supported, but whether it can be sustained over time.

In an environment where both GAAP and statutory frameworks demand careful judgment and robust documentation, that level of integration is essential.

The accounting for deferred tax assets has always required judgment, but the margin for unsupported assumptions continues to narrow. For insurance companies—particularly those with NOL-driven DTAs—the interaction between valuation allowances and statutory admissibility remains a central issue.

While the rules themselves have not changed significantly, expectations around how those rules are applied clearly have. Therefore, the distinction between projections and evidence—and between optimism and supportability—has never been more important.

Frequently Asked Questions about Valuation Allowances, Admissibility, and Deferred Tax Assets

What is a valuation allowance for deferred tax assets?
A valuation allowance is recorded under GAAP when a company determines it is not more likely than not that some or all deferred tax assets will be realized through future taxable income or other available sources.

How does statutory admissibility differ from a GAAP valuation allowance?
A valuation allowance reduces deferred tax assets under GAAP based on expected realization, while statutory admissibility rules determine how much of the remaining net deferred tax asset can be admitted for statutory surplus purposes.

Why are net operating losses important in deferred tax asset analysis?
Net operating losses often create significant deferred tax assets for insurance companies, but realizing those assets depends on sufficient future taxable income and strong supporting evidence.

What types of evidence support deferred tax asset realization?
Supportive evidence may include existing business in force, predictable deferred tax liability reversals, contractual arrangements, and established operating trends that can be objectively verified.

Why is deferred tax asset analysis especially important for insurance companies?
Deferred tax asset conclusions can affect earnings, statutory surplus, and risk based capital, making careful analysis, documentation, and coordination across departments essential for insurance companies.

For additional guidance, please contact the Larson Insurance Team.